08/07/2018
Acquires WellSpring Pharma Services for $18 Million in Cash to
Expand Contract Manufacturing Business and Accelerate ANDA
Pipeline Re-commercialization Efforts
Targets sNDA Filing for Cortrophin Gel by Q1 2020
Records Initial Royalties on Commercial Sales of Yescarta®
maceuticals Q2 2018 Earnings Release Tables
Multimedia Files: